首页> 外文OA文献 >Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI

【2h】

Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI

机译：使用PET和动态对比度增强MRI衍生的成像标记监测非小细胞肺癌对抗血管生成疗法的反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
de Langen, Adrianus J.; van den Boogaart, Vivian; Lubberink, Mark; Backes, Walter H.; Marcus, Johannes T.; van Tinteren, Harm; Pruim, Jan; Brans, Boudewijn; Leffers, Pieter; Dingemans, Anne-Marie C.; Smit, Egbert F.; Groen, Harry J. M.; Hoekstra, Otto S.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI. [J] . de Langen AJ, van den Boogaart V, Lubberink M, The Journal of Nuclear Medicine . 2011,第1期

机译：使用源自PET的成像标记和动态对比增强MRI监测非小细胞肺癌对抗血管生成治疗的反应。
2. Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI [J] . de Langen Adrianus J, van den Boogaart Vivian, Lubberink Mark, The Journal of Nuclear Medicine . 2011,第1期

机译：使用PET和动态对比度增强MRI衍生的成像标记监测非小细胞肺癌对抗血管生成疗法的反应
3. Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI [J] . Adrianus J. de Langen, Vivian van den Boogaart, Mark Lubberink, The Journal of Nuclear Medicine . 2011,第1期

机译：使用PET和动态对比度增强MRI衍生的成像标记监测非小细胞肺癌对抗血管生成治疗的反应
4. Radiomics Biomarkers from PET/CT Multi-modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-small Cell Lung Cancer Patients [C] . Wei Mu, Jin Qi, Hong Lu, SPIE Medical Imaging Conference . 2018

机译：PET / CT多模态融合图像的放射性标记生物标志物用于预测晚期非小细胞肺癌患者的免疫治疗反应
5. Oral Combination Therapy Dosage Forms for Improved Response in Resistant Non-Small Cell Lung Cancers [D] . Nottingham, Ebony. 2020

机译：口腔组合治疗剂型改善抗性非小细胞肺癌的响应
6. Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response [O] . Adam C. Yopp, Lawrence H. Schwartz, Nancy Kemeny, -1

机译：抗血管生成治疗原发性肝癌：在动态变化的相关性对比增强磁共振成像组织缺氧标志物和临床反应
7. Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI [O] . de Langen, Adrianus J., van den Boogaart, Vivian, Lubberink, Mark, 2011

机译：使用PET和动态对比度增强MRI衍生的成像标记监测非小细胞肺癌对抗血管生成疗法的反应
8. FLT-PET/CT as a Biomarker of Therapeutic Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer. [R] . Katz, S. I. 2016

机译：FLT-pET / CT作为培美曲塞治疗非小细胞肺癌治疗反应的生物标志物。

Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI

著录项

引文网络

相似文献

相关主题

期刊订阅